To better apply NKMGs to the clinical diagnosis of HCC, we screened 10 prognosis genes (KLRB1, CD7, LDB2, FCER1G, PFN1, FYN, ACTG1, PABPC1, CALM1, and RPS8). This evidence concerns the gene LDB2 and hepatocellular carcinoma.